Centralized Monitoring Under RBQM: Turning Signals into Decisions

Clinical trial teams are expected to interpret growing volumes of data faster, more consistently, and with clear rationale. RBQM helps centralized monitoring teams focus attention on signals that matter most to subject safety, data integrity, and study quality.

Why centralized monitoring has become a strategic function?

A few years ago, centralized monitoring was often viewed as a supporting activity alongside traditional monitoring. Today, it increasingly shapes oversight decisions across studies, countries, vendors, and functional teams. 

 

ICH E6(R3) reinforces expectations around ongoing risk evaluation, proportional oversight, and documented rationale. This raises an important operational question: 

How do teams ensure that signals are interpreted consistently across functions?

Many organizations already have dashboards, visualizations, and KRIs in place. The difficulty usually appears later, during interpretation and escalation. 

  • One team sees a meaningful signal.
  • Another sees normal study variation.
  • A third escalates too late. 


The operational challenge is no longer access to data. It is alignment around decision-making.
 

What QbD changes before monitoring even starts

Define critical-to-quality factors

QbD starts by identifying what could meaningfully affect subject safety, endpoint reliability, or study credibility. 

Align risks to study design

Risk discussions become connected to protocol design, data collection, and operational feasibility. 

Create monitoring relevance

Signals become meaningful because teams understand why they matter within the study context. 

Where centralized monitoring teams struggle most

Common Situation Operational Impact
Too many KRIs or alerts Teams lose prioritization
Different interpretation across functions Inconsistent actions
Weak escalation rationale Difficult inspection defense
Retrospective review cycles Delayed interventions
AI outputs without clear oversight Reduced trust in decisions

How RBQM changes centralized monitoring in practice

RBQM introduces structure around interpretation and action. 

Signals are no longer reviewed in isolation. They are evaluated against predefined study risks, operational context, and expected actions. 

This creates several operational advantages: 

  • earlier identification of emerging issues 
  • more focused oversight discussions 
  • clearer escalation pathways 
  • stronger traceability of decisions 
  • improved inspection readiness


The biggest change is often cultural. Monitoring discussions become less reactive and more structured around risk rationale.
 

Where AI can support centralized monitoring

AI-supported approaches are increasingly used to: 

  • identify unusual site or subject patterns 
  • prioritize review effort 
  • summarize large volumes of operational information 
  • support signal detection across datasets 

Teams still need to:

This is becoming increasingly important as regulators place stronger emphasis on explainability and oversight. 

Building capability across teams

STEP 1

Establish shared terminology

Ensure teams interpret CtQs, KRIs, and QTLs consistently. 

STEP 2

Align escalation logic

Define when signals require action and who owns decisions. 

STEP 3

Strengthen traceability

Ensure rationale and actions remain inspection-ready. 

STEP 4

Introduce AI in controlled workflows

Use AI-supported insights within clearly defined oversight processes. 

Key learning

Centralized monitoring becomes effective when teams share a consistent understanding of risk, interpretation, and oversight rationale.

Technology supports this process. Operational alignment makes it sustainable. 

Take the next step in your RBQM capability

Stay informed on evolving RBQM practices, expert sessions, and resources supporting clinical trial oversight.
NEWSLETTER

Using AI in clinical trials?
Be ready to explain it.

Until 11:59pm May 31st:
Get 20% early access to AI Essentials (GCP-aligned)

Aligned with GCP and computerized systems requirements.